PDCD1 and non-small cell lung carcinoma: In melanoma and NSCLC, elevated baseline LDH is associated with poor outcome of anti–PD-1 therapy (Ferrucci et al., 2015; Diem et al., 2016; Nakaya et al., 2018; Arora et al., 2019).